ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression

Gut. 2005 Apr;54(4):565. doi: 10.1136/gut.2004.055947.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Azathioprine / adverse effects*
  • Crohn Disease / genetics*
  • Drug Therapy, Combination
  • Genetic Predisposition to Disease
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Inosine Triphosphatase
  • Leukopenia / chemically induced
  • Mercaptopurine / adverse effects*
  • Pyrophosphatases / genetics*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Mercaptopurine
  • Pyrophosphatases
  • Azathioprine